Glutathione-S-transferase T1 genotyping and phenotyping in psoriasis patients receiving treatment with oral fumaric acid esters

Journal of the European Academy of Dermatology and Venereology

Volumn 28, Issue 5, 2014, Pages 574-580

  Gambichler, T ^a   Kreuter, A ^a   Susok, L ^a   Skrygan, M ^a   Rotterdam, S ^a   Hoxtermann S ^a   Muller M ^b   Tigges, C ^a   Altmeyer, P ^a   Lahner, N ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FUMADERM; FUMARIC ACID; GLUTATHIONE TRANSFERASE T1; ESTER; FUMARIC ACID DERIVATIVE; GLUTATHIONE S-TRANSFERASE T1; GLUTATHIONE TRANSFERASE;

ADULT; AGED; ALLELE; ARTICLE; DRUG WITHDRAWAL; ENZYME ACTIVITY; FEMALE; GASTROINTESTINAL SYMPTOM; GENOTYPE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSORIASIS; PSORIASIS AREA AND SEVERITY INDEX; CHEMISTRY; GENETICS; MIDDLE AGED; MOLECULAR GENETICS; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ADULT; AGED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ESTERS; FEMALE; FUMARATES; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PHENOTYPE; PSORIASIS;

EID: 84899482285     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/jdv.12137     Document Type: Article

References (38)

1. Mrowietz U, Altmeyer P, Bieber T, Röcken M, Schopf RE, Sterry W,. Teatment of psoriasis with fumaric acid esters (Fumaderm). J Dtsch Dermatol Ges 2007; 5: 716-717.
2. Mrowietz U, Christophers E, Altmeyer P,. Treatment of severe psoriasis with fumaric acid esters: scientific background and guidelines for therapeutic use. The german fumaric acid ester consensus conference. Br J Dermatol 1999; 141: 424-429.
3. Mrowietz U, Rostami-Yazdi M, Neureither M, Reich K,. [15 years of fumaderm: fumaric acid esters for the systemic treatment of moderately severe and severe psoriasis vulgaris]. J Dtsch Dermatol Ges 2009; 7 (Suppl 2): 3-16.
4. Rostami-Yazdi M, Clement B, Mrowietz U,. Pharmacokinetics of anti-psoriatic fumaric acid esters in psoriasis patients. Arch Dermatol Res 2010; 302: 531-538.
5. Gambichler T, Scola N, Rotterdam S, et al,. Monitoring peripheral blood CD4 + intracellular adenosine triphosphate concentration in patients with Psoriasis treated with fumaric acid esters. Acta Derm Venereol 2012; 92: 364-366.
6. Sau A, Pellizzari Tregno F, Valentino F, Federici G, Caccuri AM,. Glutathione transferases and development of new principles to overcome drug resistance. Arch Biochem Biophys 2010; 500: 116-122.
7. Ginsberg G, Smolenski S, Hattis D, Guyton KZ, Johns DO, Sonawane B,. Genetic Polymorphism in Glutathione Transferases (GST): population distribution of GSTM1, T1, and P1 conjugating activity. J Toxicol Environ Health B Crit Rev 2009; 12: 389-439.
8. Di Pietro G, Magno LA, Rios-Santos F,. Glutathione S-transferases: an overview in cancer research. Expert Opin Drug Metab Toxicol 2010; 6: 153-170.
9. Bolt HM, Thier R,. Relevance of the deletion polymorphisms of the glutathione S-transferases GSTT1 and GSTM1 in pharmacology and toxicology. Curr Drug Metab 2006; 7: 613-628.
10. Yan KL, Zhang XJ, Wang ZM, et al,. A novel MGST2 non-synonymous mutation in a Chinese pedigree with psoriasis vulgaris. J Invest Dermatol 2006; 126: 1003-1005.
11. Yang S, Yan KL, Zhang XJ, et al,. Systematic evaluation of association between the microsomal glutathione S-transferase 2 common variation and psoriasis vulgaris in Chinese population. Arch Dermatol Res 2006; 298: 107-112.
12. Richter-Hintz D, Their R, Steinwachs S, et al,. Allelic variants of drug metabolizing enzymes as risk factors in psoriasis. J Invest Dermatol 2003; 120: 765-770.
13. Reich K, Westphal G, Schulz T, et al,. Combined analysis of polymorphisms of the tumor necrosis factor-alpha and interleukin-10 promoter regions and polymorphic xenobiotic metabolizing enzymes in psoriasis. J Invest Dermatol 1999; 113: 214-220.
14. Piacentini S, Monaci PM, Polimanti R, Manfellotto D, Fuciarelli M,. GSTO2N142D gene polymorphism associated with hypothyroidism in Italian patients. Mol Biol Rep 2013; 40: 1967-1971.
15. Polimanti R, Piacentini S, Lazzarin N, et al,. Glutathione S-transferase genes and the risk of recurrent miscarriage in Italian women. Fertil Steril 2012; 98: 396-400.
16. Gambichler T, Tigges C, Burkert B, Höxtermann S, Altmeyer P, Kreuter A,. Absolute count of T and B lymphocyte subsets is decreased in systemic sclerosis. Eur J Med Res 2010; 15: 44-46.
17. Sprenger R, Schlagenhaufer R, Kerb R, et al,. Characterization of the glutathione S-transferase GSTT1 deletion: discrimination of all genotypes by polymerase chain reaction indicates a trimodular genotype-phenotype correlation. Pharmacogenetics 2000; 10: 557-565.
18. Müller M, Voss M, Heise C, Schulz T, Bünger J, Hallier E,. High-performance liquid chromatography/fluorescence detection of S-methylglutathione formed by glutathione-S-transferase T1 in vitro. Arch Toxicol 2001; 74: 760-767.
19. Müller M, Bünger J, Voss M, Westphal G, Ruhnau P, Hallier E,. Phenotyping of human glutathione S-transferase hGSTT1-1: a comparison of two ex vivo routine procedures. Arch Toxicol 2002; 76: 634-642.
20. Rostami-Yazdi M, Clement B, Schmidt TJ, Schinor D, Mrowietz U,. Detection of metabolites of fumaric acid esters in human urine: implications for their mode of action. J Invest Dermatol 2009; 129: 231-234.
21. Rostami Yazdi M, Mrowietz U,. Fumaric acid esters. Clin Dermatol 2008; 26: 522-526.
22. Ghashghaeinia M, Bobbala D, Wieder T, et al,. Targeting glutathione by dimethylfumarate protects against experimental malaria by enhancing erythrocyte cell membrane scrambling. Am J Physiol Cell Physiol 2010; 299: C791-C804.
23. Higgins LG, Hayes JD,. Mechanisms of induction of cytosolic and microsomal glutathione transferase (GST) genes by xenobiotics and pro-inflammatory agents. Drug Metab Rev 2011; 43: 92-137.
24. Spencer SR, Wilczak CA, Talalay P,. Induction of glutathione transferases and NAD(P)H: quinone reductase by fumaric acid derivatives in rodent cells and tissues. Cancer Res 1990; 50: 7871-7875.
25. Pastore S, Mariani V, Lulli D, et al,. Glutathione peroxidase activity in the blood cells of psoriatic patients correlates with their responsiveness to Efalizumab. Free Radic Res 2011; 45: 585-599.
26. Smith G, Weidlich S, Dawe RS, Ibbotson SH,. Glutathione S-transferase M1 (GSTM1) genotype but not GSTT1 or MC1R genotype influences erythemal sensitivity to narrow band (TL-01) UVB phototherapy. Pharmacogenet Genomics 2011; 21: 217-224.
27. Smith G, Ibbotson SH, Comrie MM, et al,. Regulation of cutaneous drug-metabolizing enzymes and cytoprotective gene expression by topical drugs in human skin in vivo. Br J Dermatol 2006; 155: 275-281.
28. Smith G, Dawe RS, Clark C, et al,. Quantitative real-time reverse transcription-polymerase chain reaction analysis of drug metabolizing and cytoprotective genes in psoriasis and regulation by ultraviolet radiation. J Invest Dermatol 2003; 121: 390-398.
29. Aceto A, Martini F, Dragani B, Bucciarelli T, Sacchetta P, Di Ilio C,. Purification and characterization of glutathione transferase from psoriatic skin. Biochem Med Metab Biol 1992; 48: 212-218.
30. Ibbotson SH, Dawe RS, Dinkova-Kostova AT, et al,. Glutathione S-transferase genotype is associated with sensitivity to psoralen-ultraviolet A photochemotherapy. Br J Dermatol 2012; 166: 380-388.
31. Kerb R, Brockmoller J, Schlagenhaufer R, Sprenger R, Roots I, Brinkmann U,. Influence of GSTT1 and GSTM1 genotypes on sunburn sensitivity. Am J Pharmacogenomics 2002; 2: 147-154.
32. Kempkes M, Wiebel FA, Golka K, Heitmann P, Bolt HM,. Comparative genotyping and phenotyping of glutathione S-transferase GSTT1. Arch Toxicol 1996; 70: 306-309.
33. Bruhn C, Brockmöller J, Kerb R, Roots I, Borchert HH,. Concordance between enzyme activity and genotype of glutathione S-transferase theta (GSTT1). Biochem Pharmacol 1998; 56: 1189-1193.
34. Wang L, Lin S,. Induction of quinone reductase and glutathion-s- transferase by dimethyl fumarate in rats. Zhonghua Yu Fang Yi Xue Za Zhi 1999; 33: 366-368.
35. Prochaska HJ, Fernandes CL,. Elevation of serum phase II enzymes by anticarcinogenic enzyme inducers: markers for a chemoprotected state? Carcinogenesis 1993; 14: 2441-2445.
36. Friling RS, Bensimon A, Tichauer Y, Daniel V,. Xenobiotic-inducible expression of murine glutathione S-transferase Ya subunit gene is controlled by an electrophile-responsive element. Proc Natl Acad Sci U S A 1990; 87: 6258-6262.
37. Höxtermann S, Nüchel C, Altmeyer P,. Fumaric acid esters suppress peripheral CD4- and CD8-positive lymphocytes in psoriasis. Dermatology 1998; 196: 223-230.
38. Wang L, Groves MJ, Hepburn MD, Bowen DT,. Glutathione S-transferase enzyme expression in hematopoietic cell lines implies a differential protective role for T1 and A1 isoenzymes in erythroid and for M1 in lymphoid lineages. Haematologica 2000; 85: 573-579.